The enhanced ufmylation of hepatic proteins could be attributed to the increased expression of ufmylation modification system components (UFM1, UBA5, UFC1, UFL1 and UFBP1) in NAFLD (Fig. 1E). Here, UFM1 is linked to metabolic dysfunction-associated steatotic liver disease.